✦ LIBER ✦

Study into the use of cetuximab in metastatic colorectal cancer in a third level hospital

✍ Scribed by J.F. Marín Pozo; B. Oya Álvarez de Morales; I. Caba Porras; J. Aranda García

Book ID: 119647737
Publisher: Elsevier
Year: 2009
Weight: 241 KB
Volume: 33
Category: Article
ISSN: 2173-5085
DOI: 10.1016/s2173-5085(09)70072-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab therapy in the treatment of me

Cetuximab therapy in the treatment of metastatic colorectal cancer: The future frontier?

✍ Gomez, D.; De Rosa, A.; Addison, A.; Brooks, A.; Malik, H.Z.; Cameron, I.C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 306 KB

PCN87 The Cost Effectiveness of Cetuxima

PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UK

✍ Perard, R.; Samyshkin, Y.; Guillermin, A.L.G. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Predictive role of multiple gene alterat

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

✍ Paola Ulivi, Laura Capelli, Martina Valgiusti, Wainer Zoli, Emanuela Scarpi, Eli 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 214 KB

Multi-drug inhibition of the HER pathway

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients

✍ Rubinson, Douglas A.; Hochster, Howard S.; Ryan, David P.; Wolpin, Brian M.; McC 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 313 KB

Pharmacogenomic and Pharmacoproteomic St

Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study

✍ Tabernero, J.; Cervantes, A.; Rivera, F.; Martinelli, E.; Rojo, F.; von Heydebre 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 264 KB

PCN14 A MODELTO DEMONSTRATE THE COMPARAT

PCN14 A MODELTO DEMONSTRATE THE COMPARATIVE COSTS BETWEEN PANITUMUMAB AND CETUXIMAB FOR THIRD-LINE METASTATIC COLORECTAL CANCER PATIENTS IN ITALY

✍ H Lamarque; JW Fitzgibbon; BJ Farrimond; RJB Lavelle; SG Eggington; A Bracco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB